|
Reckitt Benckiser Group PLC - Slough, England-based consumer health and hygiene products, including Durex, Nurofen and Vanish - Plans to commence the second tranche, worth GB250 million, of its £1 billion buyback programme initiated in July. Intends to begin the new tranche following completion of the initial £250 million tranche, which it expects to complete in October. Adds that the second buyback tranche is expected to complete by January 30 next year. It will be run by BNP Paribas. Notes the buyback programme’s purpose of increasing returns to shareholders and reducing Reckitt’s share capital. Current stock price: 5,552.00 12-month change: up 20% Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
